Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-02-22FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for LANOXIN (digoxin) submitted by Advanz Pharma (US) Corp.
-
FDA approval · 2019-01-22FDA Approved: DOFETILIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic dofetilide from Aurobindo Pharma Limited. The approval makes a generic version of the an…
-
FDA approval · 2019-01-04FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Vitruvias Therapeutics)
FDA approved Propafenone hydrochloride as an Abbreviated New Drug Application (ANDA) for a generic antiarrhythmic, with Vitruvias Therapeuti…
-
FDA approval · 2018-12-28FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Armas Pharmaceuticals Inc.)
FDA approves Armas Pharmaceuticals' verapamil hydrochloride as an original ANDA generic; standard indications for verapamil HCl include hype…
-
FDA approval · 2018-11-02FDA Approved: SOTALOL HYDROCHLORIDE AF — Original Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved Sotalol Hydrochloride AF tablets from Unichem Pharmaceuticals (USA), Inc. as an original application generic product for treati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-10-09FDA Approved: DOFETILIDE — Original Application (NorthStar RxLLC)
FDA approves NorthStar RxLLC's generic dofetilide for the maintenance of normal sinus rhythm in adults with atrial fibrillation or atrial fl…
-
FDA approval · 2018-08-30FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves Upsher-Smith's generic diltiazem hydrochloride through an original ANDA (ANDA205231) for use as a calcium channel blocker.
-
FDA approval · 2018-08-24FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Digoxin (DIGOXIN) from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2018-07-13FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's VERAPAMIL HYDROCHLORIDE as an original ANDA generic product.
-
FDA approval · 2018-06-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
The FDA approved the original application for Verapamil Hydrochloride by Somerset Therapeutics, LLC, enabling a generic version of verapamil…
-
FDA approval · 2018-06-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
FDA approves Somerset Therapeutics' Verapamil hydrochloride as an original application, granting a generic version of the drug.
-
FDA approval · 2018-06-08FDA Approved: ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved esmolol hydrochloride in sodium chloride injection (ANDA) from Mylan Institutional LLC for short-term control of heart rate in …
-
FDA approval · 2018-06-08FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved esmolol hydrochloride injection as an original generic application from Sagent Pharmaceuticals.
-
FDA approval · 2018-04-10FDA Approved: DOFETILIDE — Original Application (Bionpharma Inc.)
FDA approved a generic version of dofetilide (brand Tikosyn) from Bionpharma Inc. under ANDA208625 for atrial fibrillation and atrial flutte…
-
FDA approval · 2018-03-26FDA Approved: DOFETILIDE — Original Application (Sigmapharm Laboratories, LLC)
FDA approved the original application for dofetilide from Sigmapharm Laboratories, allowing a generic version of this antiarrhythmic to be m…
-
FDA approval · 2017-12-13FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for diltiazem hydrochloride filed by Hospira, Inc., signaling an additional approval related to the …
-
FDA approval · 2017-11-17FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for verapamil hydrochloride from Chartwell RX, LLC.
-
FDA approval · 2017-11-03FDA Approved: FLECAINIDE ACETATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approves the original application for flecainide acetate by Rising Pharma Holdings, Inc., providing a generic antiarrhythmic product. In…
-
FDA approval · 2017-10-25FDA Approved: AMIODARONE HYDROCHLORIDE — Original Application (AuroMedics Pharma LLC)
The FDA approved the original ANDA for amiodarone hydrochloride, a generic antiarrhythmic, from AuroMedics Pharma LLC.
-
FDA approval · 2017-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved Zydus Pharmaceuticals USA's original application for diltiazem hydrochloride as a generic product, enabling its use for the man…
-
FDA approval · 2017-06-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's diltiazem hydrochloride as a generic product under an original ANDA.
-
FDA approval · 2017-05-05FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved the original application for verapamil hydrochloride from Nivagen Pharmaceuticals, Inc. as a generic product.
-
FDA approval · 2017-03-22FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for Nexterone (amiodarone hydrochloride) submitted by Baxter Healthcare Company associated with NDA …
-
FDA approval · 2017-01-23FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Cardizem CD (diltiazem hydrochloride) from Bausch Health US LLC under NDA 020062, allowing c…
-
FDA approval · 2016-12-01FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for LANOXIN (digoxin) submitted by Advanz Pharma US Corp.